SCHEMBL16730757

SCHEMBL16730757

CCc1cc(-c2cccc(F)c2)n[nH]1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 4/20 0.50
ALOX15 P16050 3/20 0.50
SMN1; SMN2 Q16637 3/20 0.50
NFKB1 P19838 2/20 0.50
NFKB2 Q00653 2/20 0.50
RELA Q04206 2/20 0.50
NPSR1 Q6W5P4 2/20 0.50
LMNA P02545 2/20 0.50
MEN1 O00255 2/20 0.50
KMT2A Q03164 2/20 0.50
TP53 P04637 1/20 0.50
ALOX12 P18054 1/20 0.50
MAPK1 P28482 1/20 0.50
NPC1 O15118 1/20 0.50
CASP1 P29466 1/20 0.50
CASP3 P42574 1/20 0.50
RAB9A P51151 1/20 0.50
SENP8 Q96LD8 1/20 0.50
SENP7 Q9BQF6 1/20 0.50
SENP6 Q9GZR1 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14985490 0.82 IDO1 (0.50) MAPTALOX15SMN1; SMN2NFKB1NFKB2
SCHEMBL14985492 0.82 IDO1 (0.58) MAPTLMNATP53IDO1L3MBTL1
SCHEMBL14985512 0.81 CA12 (0.50) MAPTALOX15SMN1; SMN2LMNAMEN1
SCHEMBL1696565 0.81 L3MBTL1 (0.63) ALOX15LMNATP53RAB9APIM1
SCHEMBL14985496 0.81 ALDH1A1 (0.50) LMNAHPGDIDO1L3MBTL1NOTUM
SCHEMBL3344891 0.81 METAP2 (0.49) MAPTSMN1; SMN2LMNAMEN1KMT2A
SCHEMBL6652224 0.77 IDO1 (0.52) MAPTLMNAMAPK1HPGDIDO1
SCHEMBL14985523 0.76 COMT (0.44) SMN1; SMN2LMNANPC1RAB9AHPGD
SCHEMBL3344889 0.76 TTK (0.49) MAPTPIM1CYP2D6CYP2A6CYP2C9
SCHEMBL18179682 0.75 LMNA (0.50) LMNACASP1HPGDCOMT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2015073763-A1 SUBSTITUTED 4,5,6,7-TETRAHYDROPYRAZOLO[1,5-A]PYRAZINE DERIVATIVES AS CASEIN KINASE 1 D/E INHIBITORS BRISTOL-MYERS SQUIBB COMPANY (US) 2015-05-21 WO disclosed